Skip to main content
. 2023 Aug 29;41(30):4768–4778. doi: 10.1200/JCO.23.00529

FIG 3.

FIG 3.

Subgroup analysis of PFS (intention-to-treat population). Subgroup analyses according to randomization stratification factors categorized patients for PFI, PD-L1 status, and chemotherapy cohort as recorded in the electronic case report form. CA-125, cancer antigen-125; HR, hazard ratio; PFS, progression-free survival; PLD, pegylated liposomal doxorubicin; SLD, sum of largest diameter.